Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019

患者エンゲージメント・ソリューション(ハードウェア、ソフトウェア、サービス)の世界市場

◆タイトル:Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019
◆商品コード:MAM-HIT2767
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年9月
◆ページ数:189
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single user(1名使用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User(5名まで使用)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate licence(全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"患者エンゲージメント・ソリューション(ハードウェア、ソフトウェア、サービス)の世界市場"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場の成長要因、阻害要因、市場の機会と課題、産業動向、市場の動態、用途別分析、構成要素別分析、需要先別分析、方式別分析、治療分野別分析、市場規模及び予測、競争状況、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The healthcare industry is undergoing a fundamental transformation globally as it shifts from a volume-based to a value-based one. Growing demand from consumers for improved healthcare quality and greater value are forcing healthcare providers and payers to deliver optimized outcomes. In addition, governments across the globe are working toward reducing healthcare costs, which increases the burden on payers and providers to meet government as well as consumer expectations, thereby compelling them to move towards patient engagement solutions.

The global patient engagement solutions market is estimated to grow at a CAGR of 20% from 2014 to 2019, to reach $13.7 billion by 2019 from $5.5 billion in 2014.Over the years, the traditional approaches to patient care, quality assurance, and cost management have been inefficient. Therefore patient engagement solutions will be among the priorities on the investment list of healthcare organizations for improving quality outcomes and cost management. Based on the mode of delivery, web-based solutions accounted for the largest segment of the patient engagement solutions market in 2014. However, cloud-based solutions are the fastest-growing delivery modes.
Based on end users, the providers segment accounted for the largest share. However, the providers and payers segments are expected to grow at a rapid rate in the end-user market.
Based on applications, health management accounted for the largest share of the patient engagement solutions market in 2014. Chronic disease contributed to the largest share of the market, by therapeutic area and it is expected to grow at a rapid rate.

Based on geography, North America contributed to the largest share of the market. The large share of this region can be attributed to factors such as rising healthcare costs and demand for quality care, legislative reforms, rising aging and chronically ill population, and government support for patient engagement.

The patient engagement solutions market is highly fragmented with many small and large players. Companies in this market focus on growth strategies such as client acquisitions; agreements, partnerships, collaborations; new product launches; expansions; acquisitions; marketing and promotion; and others (funding, grant, product enhancement) to increase their customer base.

The major players in the global patient engagement solutions market include McKesson Corporation (U.S.), Medecision, Inc. (U.S.), Allscripts, Inc. (U.S.), Phytel Inc. (U.S.), Cerner Corporation (U.S.), Orion Health (New Zealand), Aetna, Inc. (U.S.), Athenahealth, Inc. (U.S.), Emmi Solutions LLC (U.S.), and GetWellNetwork, Inc. (U.S.).

[Reasons to Buy the Report]:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolio and services offered by the ten major players in the patient engagement solutions market. The report analyzes patient engagement solutions across geographies

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the patient engagement solutions market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the patient engagement solutions market across geographies

• Market Diversification: Extensive information about new products and services, untapped geographies, recent developments, and investments in the patient engagement solutions market

• Competitive Assessment: In-depth assessment of strategies, products, and services of leading players in the patient engagement solutions market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKETS COVERED 18
1.3 STAKEHOLDERS 20
1.4 MARKET SCOPE 20

2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 21
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.1.1.1 Secondary Research 21
2.1.2 KEY DATA FROM SECONDARY SOURCES 22
2.1.2.1 Primary Research 23
2.1.3 KEY DATA FROM PRIMARY SOURCES 24
2.1.4 KEY INSIGHTS FROM PRIMARY SOURCES 24
2.1.4.1 Key Industry Insights 25
2.1.5 MARKET SIZE ESTIMATION METHODOLOGY 25
2.1.6 MARKET FORECAST METHODOLOGY 28
2.1.7 MARKET DATA VALIDATION AND DATA TRIANGULATION 28
2.1.8 ASSUMPTIONS 29
2.1.9 LIMITATIONS 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 33
4.1 ATTRACTIVE OPPORTUNITIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET 33
4.3 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 34
4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER AND GEOGRAPHY 35
4.6 CAGR% (2014–2019) ACROSS GEOGRAPHIES 36

5 MARKET DYNAMICS 37
5.1 DRIVERS 38
5.1.1 IMPLEMENTATION OF ACT 38
5.1.2 RISE IN NUMBER OF ACCOUNTABLE CARE ORGANIZATIONS 38
5.1.3 FEDERAL MANDATE ENCOURAGES USE OF PATIENT ENGAGEMENT SOLUTIONS AMONG STAKEHOLDERS 39
5.1.4 RISE IN AGING POPULATION AND INCIDENCES OF CHRONIC DISEASES 39
5.1.5 INCENTIVES BY FEDERAL GOVERNMENT 40
5.1.6 HIGH RETURN ON INVESTMENT 42
5.1.7 HIGH INVESTMENTS BY PAYERS AND PROVIDERS 42
5.1.8 ADVANCED IT AND BIG DATA CAPABILITIES 43
5.1.9 INCREASING AWARENESS OF MOBILE HEALTH (M-HEALTH) 43
5.2 RESTRAINTS 43
5.2.1 NECESSITY OF CHANGE IN POLICIES AS WELL AS MIND-SET OF PROVIDERS 43
5.2.2 REQUIREMENT OF INFRASTRUCTURAL INVESTMENTS 44
5.2.3 LACK OF CONFIDENCE IN PATIENT ENGAGEMENT SOLUTIONS 44
5.2.4 FRAGMENTED END-USER MARKET 45
5.2.5 PROTECTION OF PATIENT INFORMATION 45
5.2.6 LACK OF HEALTH LITERACY 46
5.2.7 POOR ACCESS TO HEALTHCARE 46
5.3 OPPORTUNITIES 46
5.3.1 JAPAN & AUSTRALIA OFFER HUGE MARKET POTENTIAL 46
5.3.2 GROWING MEDICAL TOURISM 46
5.3.3 CLOUD-BASED MODELS 47

6 INDUSTRY TRENDS 48
6.1 FORCE-FIELD ANALYSIS 48
6.1.1 DRIVING FORCES 48
6.1.1.1 Awareness amongst patients about patient engagement solutions (PES) 48
6.1.1.2 Benefits to patients/patient empowerment 48
6.1.1.3 Ease of use 49
6.1.2 RESTRAINING FORCES 49
6.1.2.1 Requirement of healthcare information technology (HCIT) infrastructure 49
6.1.2.2 Reluctance of patients 49
6.1.2.3 Health information safety concerns 49
6.1.3 FORCE FIELD ANALYSIS 50
6.2 END-USER MARKET POTENTIAL ANALYSIS 52
6.3 PATIENT ENGAGEMENT MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES 53
6.3.1 ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES 53
6.3.2 ORGANIC GROWTH STRATEGIES 54
6.3.3 INORGANIC GROWTH STRATEGIES 56

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 58
7.1 INTRODUCTION 59
7.2 HARDWARE 60
7.3 SOFTWARE 61
7.3.1 STANDALONE SOLUTIONS 62
7.3.2 INTEGRATED SOLUTIONS 63
7.4 SERVICES 64
7.4.1 CONSULTING SERVICES 65
7.4.2 IMPLEMENTATION SERVICES 65
7.4.3 TRAINING & EDUCATION SERVICES 65
7.4.4 OTHER SERVICES 65
7.4.4.1 Post-Sale & Maintenance Services 65
7.4.4.2 Advertising Services 65
7.4.4.3 Enrollment Services 66

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY MODE OF DELIVERY 67
8.1 INTRODUCTION 68
8.2 WEB–BASED DELIVERY 70
8.3 ON–PREMISE 71
8.4 CLOUD-BASED 72

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 73
9.1 INTRODUCTION 74
9.2 PROVIDERS 75
9.3 PAYERS 76
9.4 PATIENTS 77
9.5 OTHERS 78

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 79
10.1 INTRODUCTION 80
10.2 HEALTH MANAGEMENT 82
10.3 SOCIAL AND BEHAVIORAL MANAGEMENT 83
10.4 HOME HEALTH MANAGEMENT 84
10.5 FINANCIAL HEALTH MANAGEMENT 85

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 86
11.1 INTRODUCTION 87
11.2 CHRONIC DISEASES 88
11.2.1 DIABETES 89
11.2.2 CARDIOVASCULAR DISEASE 90
11.2.3 OBESITY 91
11.2.4 OTHER CHRONIC DISEASES 92
11.3 WOMEN’S HEALTH 92
11.4 FITNESS 93
11.5 OTHER THERAPEUTIC AREAS 94

12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY GEOGRAPHY 95
12.1 INTRODUCTION 96
12.2 U.S. 102
12.2.1 PATIENT ENGAGEMENT SOLUTIONS A VITAL TOOL IN CURBING HEALTHCARE COSTS IN THE U.S. 102
12.2.2 REGULATORY MANDATES BY ACA STIMULATING THE U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET 102
12.2.3 AGING POPULATION IN THE U.S. TO AID THE GROWTH OF THE PES MARKET 103
12.2.4 RISING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET 103
12.3 CANADA 107
12.4 EUROPE 111
12.4.1 RISE IN HEALTHCARE COSTS, AGING POPULATION LIKELY TO STIMULATE EUROPEAN MARKET 111
12.4.2 EHRS LAYING THE FOUNDATION FOR ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS 111
12.4.3 GROWTH OF HCIT MARKET, CONSOLIDATION OF HEALTHCARE PROVIDERS IN EUROPE BODES WELL FOR PES MARKET 111
12.4.4 CONFERENCES TO CREATE AWARENESS ABOUT PATIENT ENGAGEMENT SOLUTIONS 112
12.5 ASIA 116
12.5.1 GROWTH IN MEDICAL TOURISM SET TO PROPEL ASIAN PATIENT ENGAGEMENT SOLUTIONS MARKET 116
12.5.2 PATIENT ENGAGEMENT SOLUTIONS A WAY TO CONTROL RISING HEALTHCARE EXPENDITURE IN INDIA 116
12.5.3 INCREASE IN INVESTMENT BY JAPAN IN HEALTHCARE ICT SECTOR TO STIMULATE THE MARKET 116
12.6 REST OF THE WORLD 121
12.6.1 HEALTHCARE INVESTMENTS IN THE MIDDLE EAST BOOSTING PATIENT ENGAGEMENT SOLUTIONS MARKET 121
12.6.2 GROWTH OF HCIT MARKET IN LATIN AMERICA LIKELY TO PROPEL PATIENT ENGAGEMENT SOLUTIONS MARKET 121
12.6.3 AUSTRALIA IMPLEMENTING A NUMBER OF HCIT PROGRAMS 121

13 COMPETITIVE LANDSCAPE 126
13.1 INTRODUCTION 126
13.2 CLIENT ACQUISITIONS 128
13.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 130
13.4 NEW PRODUCT LAUNCHES 132
13.5 EXPANSIONS 134
13.6 ACQUISITIONS 136
13.7 MARKETING AND PROMOTIONAL ACTIVITIES 137
13.8 OTHERS 140

14 COMPANY PROFILES 142
14.1 AETNA, INC. 142
14.2 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 148
14.3 ATHENAHEALTH, INC. 152
14.4 CERNER CORPORATION 158
14.5 EMMI SOLUTIONS LLC 161
14.6 GETWELLNETWORK, INC. 164
14.7 MCKESSON CORPORATION 168
14.8 MEDECISION, INC. 172
14.9 ORION HEALTH 175
14.10 PHYTEL, INC. 178

*Details on Business Overview, Financial Overview, Services Offered, Key Strategy, and Recent Developments might not be captured in case of unlisted companies.

15 APPENDIX 183
15.1 DISCUSSION GUIDE 183
15.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 186
15.3 AVAILABLE CUSTOMIZATIONS 188
15.4 RELATED REPORTS 188

LIST OF TABLES (90)

TABLE 1 NUMBER OF ACCOUNTABLE CARE ORGANIZATIONS IN THE U.S., 2010–2013 39
TABLE 2 MEDICARE EHR INCENTIVE TIMELINE 40
TABLE 3 MEDICAID HITECH INCENTIVE TIMELINE 40
TABLE 4 HITECH E-PRESCRIBE BONUS 41
TABLE 5 HITECH ACT - SUBSIDY PLAN 41
TABLE 6 AFFORDABLE CARE ACT BOOSTING TO ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS 41
TABLE 7 MINDSET AND POLICY CHANGES NEEDED FOR SUCCESSFUL IMPLEMENTATION OF PATIENT ENGAGEMENT SOLUTIONS 44
TABLE 8 EMERGING MARKETS OFFER HUGE POTENTIAL FOR PATIENT ENGAGEMENT SOLUTIONS 47
TABLE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT,
2012–2019 ($MILLION) 59
TABLE 10 PATIENT ENGAGEMENT HARDWARE MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 60
TABLE 11 PATIENT ENGAGEMENT SOFTWARE MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 62
TABLE 12 PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 62
TABLE 13 PATIENT ENGAGEMENT STANDALONE SOLUTIONS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 63
TABLE 14 PATIENT ENGAGEMENT INTEGRATED SOLUTIONS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 64
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS SERVICES MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 64
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY,
2012–2019 ($MILLION) 69
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR WEB–BASED SOLUTIONS, BY REGION, 2012–2019 ($MILLION) 70
TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR ON-PREMISE SOLUTIONS, BY REGION, 2012–2019 ($MILLION) 71
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CLOUD–BASED SOLUTIONS, BY REGION, 2012–2019 ($MILLION) 72
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 75
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR PROVIDERS, BY REGION, 2012–2019 ($MILLION) 76
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR PAYERS, BY REGION, 2012–2019 ($MILLION) 76
TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR PATIENTS, BY REGION, 2012–2019 ($MILLION) 77
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER END USERS,
BY REGION, 2012–2019 ($MILLION) 78
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 81
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTH MANAGEMENT,
BY REGION, 2012–2019 ($MILLION) 82
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR SOCIAL AND BEHAVIORAL MANAGEMENT, BY REGION, 2012–2019 ($MILLION) 83
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HOME HEALTH MANAGEMENT, BY REGION, 2012–2019 ($MILLION) 84
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2012–2019 ($MILLION) 85
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA,
2012–2019 ($MILLION) 87
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CHRONIC DISEASES,
BY TYPE, 2012–2019 ($MILLION) 88
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CHRONIC DISEASES,
BY REGION, 2012–2019 ($MILLION) 89
TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR DIABETES MANAGEMENT, BY REGION, 2012–2019 ($MILLION) 90
TABLE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CARDIOVASCULAR DISEASE, BY REGION, 2012–2019 ($MILLION) 90
TABLE 35 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OBESITY, BY REGION, 2012–2019 ($MILLION) 91
TABLE 36 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER CHRONIC DISEASES, BY REGION, 2012–2019 ($MILLION) 92
TABLE 37 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR WOMEN’S HEALTH,
BY REGION, 2012–2019 ($MILLION) 93
TABLE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR FITNESS SOLUTIONS,
BY REGION, 2012–2019 ($MILLION) 93
TABLE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER THERAPEUTIC AREAS, BY REGION, 2012–2019 ($MILLION) 94
TABLE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY GEOGRAPHY,
2012–2019 ($MILLION) 97
TABLE 41 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2012–2019 ($MILLION) 99
TABLE 42 NORTH AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2012–2019 ($MILLION) 99
TABLE 43 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2012–2019 ($MILLION) 99
TABLE 44 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2012–2019 ($MILLION) 100
TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2012–2019 ($MILLION) 100
TABLE 46 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2012–2019 ($MILLION) 101
TABLE 47 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY CHRONIC DISEASE, 2012–2019 ($MILLION) 101
TABLE 48 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION) 102
TABLE 49 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2012–2019 ($MILLION) 104
TABLE 50 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2012–2019 ($MILLION) 104
TABLE 51 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2012–2019 ($MILLION) 105
TABLE 52 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2012–2019 ($MILLION) 105
TABLE 53 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2012–2019 ($MILLION) 106
TABLE 54 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2012–2019 ($MILLION) 106
TABLE 55 U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY CHRONIC DISEASE,
2012–2019 ($MILLION) 107
TABLE 56 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2012–2019 ($MILLION) 107
TABLE 57 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2012–2019 ($MILLION) 108
TABLE 58 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY MODE OF DELIVERY, 2012–2019 ($MILLION) 108
TABLE 59 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2012–2019 ($MILLION) 109
TABLE 60 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2012–2019 ($MILLION) 109
TABLE 61 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2012–2019 ($MILLION) 110
TABLE 62 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY CHRONIC DISEASE, 2012–2019 ($MILLION) 110
TABLE 63 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2012–2019 ($MILLION) 112
TABLE 64 EUROPE PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2012–2019 ($MILLION) 112
TABLE 65 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2012–2019 ($MILLION) 113
TABLE 66 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2012–2019 ($MILLION) 113
TABLE 67 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2012–2019 ($MILLION) 114
TABLE 68 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2012–2019 ($MILLION) 114
TABLE 69 EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY CHRONIC DISEASE, 2012–2019 ($MILLION) 115
TABLE 70 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2012–2019 ($MILLION) 117
TABLE 71 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2012–2019 ($MILLION) 117
TABLE 72 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2012–2019 ($MILLION) 118
TABLE 73 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2012–2019 ($MILLION) 118
TABLE 74 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2012–2019 ($MILLION) 119
TABLE 75 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2012–2019 ($MILLION) 119
TABLE 76 ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY CHRONIC DISEASE,
2012–2019 ($MILLION) 120
TABLE 77 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2012–2019 ($MILLION) 122
TABLE 78 ROW: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE,
2012–2019 ($MILLION) 122
TABLE 79 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2012–2019 ($MILLION) 123
TABLE 80 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2012–2019 ($MILLION) 123
TABLE 81 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2012–2019 ($MILLION) 124
TABLE 82 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2012–2019 ($MILLION) 124
TABLE 83 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY CHRONIC DISEASE,
2012–2019 ($MILLION) 125
TABLE 84 CLIENT ACQUISITIONS, 2012–2014 129
TABLE 85 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2012–2014 131
TABLE 86 NEW PRODUCT LAUNCHES, 2012–2014 133
TABLE 87 EXPANSIONS, 2013–2014 135
TABLE 88 ACQUISITIONS, 2012–2014 137
TABLE 89 MARKETING AND PROMOTIONAL ACTIVITIES, 2012–2014 139
TABLE 90 OTHER STRATEGIES, 2012–2014 141

LIST OF FIGURES (44)

FIGURE 1 PATIENT ENGAGEMENT SOLUTIONS MARKET SEGMENTATION 18
FIGURE 2 RESEARCH METHODOLOGY STEPS 21
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 23
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (1/3) 25
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (2/3) 26
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (3/3) 26
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 8 MARKET FORECAST METHODOLOGY 28
FIGURE 9 DATA TRIANGULATION METHODOLOGY 29
FIGURE 10 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE SNAPSHOT (2014 VS. 2019) 30
FIGURE 11 ASIA IS THE FASTEST-GROWING MARKET FOR PATIENT ENGAGEMENT SOLUTIONS 31
FIGURE 12 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET TO ACHIEVE GROWTH OF 150% FROM 2014—2019 33
FIGURE 13 CHRONIC DISEASE APPLICATION SEGMENT WILL COMMANDS 50% OF THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET 34
FIGURE 14 NORTH AMERICAN PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE 2014 = $3.8 BILLION 35
FIGURE 15 ASIAN PATIENT ENGAGEMENT SOLUTIONS MARKET TO HAVE HIGHEST CAGR BETWEEN 2014 AND 2019 36
FIGURE 16 MARKET DYNAMICS 38
FIGURE 17 FORCE FIELD ANALYSIS: THE ADOPTION OF PES BY PATIENTS IS EXPECTED TO INCREASE IN THE FUTURE 51
FIGURE 18 HEALTHCARE PROVIDERS ARE THE DOMINANT END USERS IN THE U.S. FOR PATIENT ENGAGEMENT SOLUTIONS 52
FIGURE 19 ORGANIC AND INORGANIC GROWTH STRATEGIES 54
FIGURE 20 INDICATIVE LIST OF ORGANIC GROWTH STRATEGIES (2012–2014) 55
FIGURE 21 ORGANIC GROWTH STRATEGIES, BY COMPANY (2012–2014) 55
FIGURE 22 INDICATIVE LIST OF INORGANIC GROWTH STRATEGIES (2012–2014) 56
FIGURE 23 INORGANIC GROWTH STRATEGIES, BY COMPANY (2012–2014) 57
FIGURE 24 SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE PATIENT ENGAGEMENT SOLUTIONS MARKET 59
FIGURE 25 PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE 61
FIGURE 26 SOFTWARE MARKET TO WITNESS HIGHEST GROWTH IN NORTH AMERICA 61
FIGURE 27 PATIENT ENGAGEMENT SOLUTION: DELIVERY MODE 68
FIGURE 28 CLOUD-BASED MODE OF DELIVERY POISED TO GROW AT HIGHEST CAGR (2014 VS. 2019) 69
FIGURE 29 THE PROVIDER SEGMENT IS THE FASTEST-GROWING SEGMENT IN THE PATIENT ENGAGEMENT SOLUTIONS END-USER MARKET 74
FIGURE 30 HEALTH MANAGEMENT DOMINATES PATIENT ENGAGEMENT APPLICATIONS MARKET 80
FIGURE 31 ASIA IS THE FASTEST-GROWING REGION IN THE GLOBAL HEALTH MANAGEMENT SOLUTIONS MARKET 81
FIGURE 32 CHRONIC DISEASES SEGMENT DOMINATING PES MARKET (BY THERAPEUTIC AREA) 87
FIGURE 33 ASIA-PACIFIC THE FASTEST-GROWING SEGMENT OF PES MARKET FOR CHRONIC DISEASE SOLUTIONS 88
FIGURE 34 GEOGRAPHIC SNAPSHOT (2013) – RAPID GROWTH MARKETS ARE EMERGING AS NEW HOT SPOTS 96
FIGURE 35 NORTH AMERICAN MARKET SNAPSHOT: DEMAND WILL BE DRIVEN BY INCREASING NUMBER OF ACOS, PREVALENCE OF CHRONIC DISEASES 98
FIGURE 36 CLIENT ACQUISITIONS WAS THE KEY STRATEGY DURING 2012–2014 126
FIGURE 37 BATTLE FOR MARKET SHARE: COMPANIES DEPENDED ON CLIENT ACQUISITIONS FOR EXPANDING MARKET SHARE 127
FIGURE 38 CLIENT ACQUISITIONS, BY COMPANY, 2012–2014 128
FIGURE 39 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, BY COMPANY, 2012–2014 130
FIGURE 40 NEW PRODUCT LAUNCHES, BY COMPANY, 2012–2014 132
FIGURE 41 EXPANSIONS, BY COMPANY, 2012–2014 134
FIGURE 42 ACQUISITIONS, BY COMPANY, 2012–2014 136
FIGURE 43 MARKETING AND PROMOTIONAL ACTIVITIES, BY COMPANY, 2012–2014 138
FIGURE 44 OTHER STRATEGIES, BY COMPANY, 2010–2014 140

【レポートのキーワード】

患者エンゲージメント・ソリューション、ハードウェア、ソフトウェア、サービス、病院、健康管理、医療IT

★調査レポート[患者エンゲージメント・ソリューション(ハードウェア、ソフトウェア、サービス)の世界市場] ( Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019 / MAM-HIT2767) 販売に関する免責事項
[患者エンゲージメント・ソリューション(ハードウェア、ソフトウェア、サービス)の世界市場] ( Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019 / MAM-HIT2767) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆